Silence Therapeutics plc (SLN)
NASDAQ·Healthcare·Biotechnology
$11.42
+6.93%
Mkt Cap $292.38M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
Implied Upside
+399.1%
Consensus $57.00 vs current $11.42
NASDAQ·Healthcare·Biotechnology
$11.42
+6.93%
Mkt Cap $292.38M
No recent rating data.
Price Target (5 analysts)
$57.00
Range $49.00 – $67.00
+399.1%
Consensus $57.00 vs current $11.42